Detalles de la búsqueda
1.
A human embryonic limb cell atlas resolved in space and time.
Nature
; 2023 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057666
2.
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial.
Lancet
; 402(10409): 1272-1281, 2023 10 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37708904
3.
Smoking, tobacco dependence, and neurometabolites in the dorsal anterior cingulate cortex.
Mol Psychiatry
; 28(11): 4756-4765, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37749232
4.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal cancer treatment (ICON8): overall survival results from an open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 23(7): 919-930, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690073
5.
Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian carcinoma.
Gynecol Oncol
; 167(3): 404-413, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36273926
6.
Combined effects of increased water temperature and cyanobacterial compounds exert heterogeneous effects on survival and ecological processes in key freshwater species.
Oecologia
; 200(3-4): 515-528, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36342526
7.
Getting the MOST out of follow-up: a randomized controlled trial comparing 3 monthly nurse led follow-up via telehealth, including monitoring CA125 and patient reported outcomes using the MOST (Measure of Ovarian Symptoms and Treatment concerns) with routine clinic based or telehealth follow-up, after completion of first line chemotherapy in patients with epithelial ovarian cancer.
Int J Gynecol Cancer
; 32(4): 560-565, 2022 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34551895
8.
A rare case of paediatric astroblastoma with concomitant MN1-GTSE1 and EWSR1-PATZ1 gene fusions altering management.
Neuropathol Appl Neurobiol
; 47(6): 882-888, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33534137
9.
Rucaparib maintenance treatment for recurrent ovarian carcinoma: the effects of progression-free interval and prior therapies on efficacy and safety in the randomized phase III trial ARIEL3.
Int J Gynecol Cancer
; 31(7): 949-958, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103386
10.
Visible light photocatalytic bismuth oxide coatings are effective at suppressing aquatic cyanobacteria and degrading free-floating genomic DNA.
J Environ Sci (China)
; 104: 128-136, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33985716
11.
Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Lancet Oncol
; 21(7): 969-977, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32615110
12.
Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 21(5): 710-722, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32359490
13.
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Lancet Oncol
; 21(5): 699-709, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32305099
14.
Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial.
Lancet
; 394(10214): 2084-2095, 2019 12 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31791688
15.
Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production.
Metab Eng
; 57: 203-216, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31805379
16.
The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma.
Gynecol Oncol
; 159(1): 101-111, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32861537
17.
Toxin-mediated competition in weakly motile bacteria.
J Theor Biol
; 480: 205-217, 2019 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31348925
18.
Measuring response to neoadjuvant chemotherapy in high-grade serous tubo-ovarian carcinoma: an analysis of the correlation between CT imaging and chemotherapy response score.
Int J Gynecol Cancer
; 2019 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31097511
19.
Macroalgae as spatial and temporal bioindicators of coastal metal pollution following remediation and diversion of acid mine drainage.
Ecotoxicol Environ Saf
; 182: 109458, 2019 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-31398784
20.
Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 390(10106): 1949-1961, 2017 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28916367